Structure-Based Discovery and Development of Highly Potent Dihydroorotate Dehydrogenase Inhibitors for Malaria Chemoprevention
Open Access
- 23 December 2024
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 68 (1) , 590-637
Abstract
Malaria remains a serious global health challenge, yet treatment and control programs are threatened by drug resistance. Dihydroorotate dehydrogenase (DHODH) was clinically validated as a target for treatment and prevention of malaria through human studies with DSM265, but currently no drugs against this target are in clinical use. We used structure-based computational tools including free energy perturbation (FEP+) to discover highly ligand efficient, potent, and selective pyrazole-based Plasmodium DHODH inhibitors through a scaffold hop from a pyrrole-based series. Optimized pyrazole-based compounds were identified with low nM-to-pM Plasmodium falciparum cell potency and oral activity in a humanized SCID mouse malaria infection model. The lead compound DSM1465 is more potent and has improved absorption, distribution, metabolism and excretion/pharmacokinetic (ADME/PK) properties compared to DSM265 that support the potential for once-monthly chemoprevention at a low dose. This compound meets the objective of identifying compounds with potential to be used for monthly chemoprevention in Africa to support malaria elimination efforts.Keywords
Funding Information
- Welch Foundation (I-1257, I-2155-20230405)
- Bill and Melinda Gates Foundation (035132, 26296)
- Medicines for Malaria Venture
- U.S. Department of Energy (DE-AC02-06CH11357, DE-AC02-76SF00515)
- National Institutes of Health (1S10OD026758, P30GM133894, R01AI103947, R01GM141088)
This publication has 77 references indexed in Scilit:
- Identification of potent and reversible piperidine carboxamides that are species-selective orally active proteasome inhibitors to treat malariaCell Chemical Biology, 2024
- In Vitro - in Vivo Extrapolation of Hepatic Clearance in Preclinical SpeciesPharmaceutical Research, 2022
- The antimalarial resistome – finding new drug targets and their modes of actionCurrent Opinion in Microbiology, 2020
- Phenotypic Screens in Antimalarial Drug DiscoveryTrends in Parasitology, 2016
- Yeast dihydroorotate dehydrogenase as a new selectable marker for Plasmodium falciparum transfectionMolecular and Biochemical Parasitology, 2011
- In-vitro culture of Plasmodium falciparum: Utility of modified (RPNI) medium for drug-sensitivity studies using SYBR Green I assayExperimental Parasitology, 2011
- Quantitative measurement of Plasmodium‐infected erythrocytes in murine models of malaria by flow cytometry using bidimensional assessment of SYTO‐16 fluorescenceCytometry Part A, 2008
- Dissolution Media Simulating Conditions in the Proximal Human Gastrointestinal Tract: An UpdatePharmaceutical Research, 2008
- In vitro cultivation of Plasmodium falciparum: Studies with modified medium supplemented with ALBUMAX II and various animal seraExperimental Parasitology, 2007
- Orthogonal Multipolar Interactions in Structural Chemistry and BiologyAngewandte Chemie International Edition, 2005